A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA
Clinical trial NCT00693186 · COMPLETED
Trial details
- NCT number
- NCT00693186
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.